| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
18,740,000 |
| Market
Cap: |
108.13(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.38 - $6.65 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 20.7 |
| Insider 6 Months : 20.7 |
| Insider 3/6 Months : 41.3 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile DiaMedica Therapeutics is a biopharmaceutical company engaged in developing novel therapeutic products to improve the lives of people with Type 1 diabetes, Type 2 diabetes and other significant diseases with unmet medical needs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
4,799,999 |
4,799,999 |
4,799,999 |
7,219,999 |
| Total Buy Value |
$16,799,997 |
$16,799,997 |
$16,799,997 |
$22,849,197 |
| Total People Bought |
3 |
3 |
3 |
4 |
| Total Buy Transactions |
3 |
3 |
3 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-05-22 |
2025-02-18 |
2024-08-20 |
2023-08-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jacinto Richard Ii |
10% Owner |
• • • |
2025-07-23 |
4 |
B |
$3.50 |
$1,400,000 |
I/I |
400,000 |
4,958,823 |
1.5 |
17% |
|
| Tomeqt Private Ab |
10% Owner |
– – • |
2025-07-23 |
4 |
B |
$3.50 |
$9,999,997 |
I/I |
2,857,142 |
8,383,577 |
1.5 |
17% |
|
| Trill Ab |
10% Owner |
– – • |
2025-07-23 |
4 |
B |
$3.50 |
$5,400,000 |
I/I |
1,542,857 |
6,764,465 |
1.5 |
17% |
|
| Pilnik Richard D. |
Director |
– • – |
2025-04-07 |
4 |
OE |
$2.11 |
$50,640 |
D/D |
24,000 |
312,995 |
|
- |
|
| Giuffre Randall Michael |
Director |
– • – |
2025-02-13 |
4 |
OE |
$2.11 |
$43,570 |
D/D |
17,000 |
392,412 |
|
- |
|
| Pilnik Richard D. |
Director |
– • – |
2025-01-02 |
4 |
A |
$5.34 |
$55,499 |
D/D |
10,393 |
288,995 |
|
- |
|
| Parsons James T. |
Director |
– • – |
2025-01-02 |
4 |
A |
$5.34 |
$84,997 |
D/D |
15,917 |
75,854 |
|
- |
|
| Kuntz Richard |
Director |
– • – |
2025-01-02 |
4 |
A |
$5.34 |
$53,000 |
D/D |
9,925 |
24,210 |
|
- |
|
| Semba Charles Pauling |
Director |
– • – |
2025-01-02 |
4 |
A |
$5.34 |
$28,249 |
D/D |
5,290 |
44,608 |
|
- |
|
| Giuffre Randall Michael |
Director |
– • – |
2025-01-02 |
4 |
A |
$5.34 |
$57,998 |
D/D |
10,861 |
375,412 |
|
- |
|
| Tomeqt Private Ab |
10% Owner |
– – • |
2024-06-28 |
4 |
B |
$2.50 |
$3,000,000 |
I/I |
1,200,000 |
5,526,435 |
1.5 |
47% |
|
| Trill Ab |
10% Owner |
– – • |
2024-06-28 |
4 |
B |
$2.50 |
$3,000,000 |
I/I |
1,200,000 |
5,221,608 |
1.5 |
47% |
|
| Pilnik Richard D. |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$85,000 |
D/D |
30,357 |
278,602 |
|
- |
|
| Giuffre Randall Michael |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$53,749 |
D/D |
19,196 |
364,551 |
|
- |
|
| Parsons James T. |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$59,998 |
D/D |
21,428 |
59,937 |
|
- |
|
| Semba Charles Pauling |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$26,250 |
D/D |
9,375 |
39,318 |
|
- |
|
| Kuntz Richard |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$39,998 |
D/D |
14,285 |
14,285 |
|
- |
|
| Wambeke David J. |
Chief Business Officer |
• – – |
2023-11-16 |
4 |
B |
$2.46 |
$49,200 |
D/D |
20,000 |
527,114 |
2.74 |
16% |
|
| Tomeqt Private Ab |
10% Owner |
– – • |
2023-06-23 |
4 |
B |
$3.40 |
$4,999,999 |
I/I |
1,470,588 |
4,326,435 |
1.5 |
-49% |
|
| Pauls Dietrich John |
President and CEO |
• • – |
2023-06-23 |
4 |
B |
$3.91 |
$49,997 |
D/D |
12,787 |
68,591 |
2.81 |
-49% |
|
| Wambeke David J. |
Chief Business Officer |
• – – |
2023-06-23 |
4 |
B |
$3.91 |
$150,003 |
D/D |
38,364 |
507,114 |
2.74 |
-49% |
|
| Kellen Scott |
CFO and Secretary |
• – – |
2023-06-23 |
4 |
B |
$3.91 |
$39,100 |
D/D |
10,000 |
32,290 |
2.74 |
-49% |
|
| Pilnik Richard D. |
Director |
– • – |
2023-06-23 |
4 |
B |
$3.91 |
$149,999 |
D/D |
38,363 |
248,245 |
2.39 |
-49% |
|
| Giuffre Randall Michael |
Director |
– • – |
2023-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
345,355 |
|
- |
|
| Giuffre Randall Michael |
Director |
– • – |
2023-06-23 |
4 |
B |
$3.91 |
$254,150 |
D/D |
65,000 |
360,355 |
2.39 |
-49% |
|
79 Records found
|
|
Page 1 of 4 |
|
|
0.01 (0.17%) 
